Midas Letter

Sama Resources Inc (CVE:SME) (OTCMKTS:SAMMF) (FRA:8RS) CEO Marc-Antoine Audet provides an introduction to the company and shares details of its recent operations. Sama is a resource company focused on the exploration of the Samapleu Nickel-Copper project in Côte d’Ivoire. The site features nickel and copper sulphides at surface and has yielded finds of cobalt, silver, platinum, and palladium. Sama began a new drill program in January to look for the source of the surface sulphide. Sama is using HPX’s Typhoon system to provide greater mapping detail of the geological system.

Narrator: Sama Resources Inc. is a Canadian-based mineral exploration and development company with projects in West Africa. The company is focused on exploring the Samapleu nickel/copper project in Ivory Coast.

In October 2017, Sama announced that it has entered into a binding term sheet to form a strategic partnership with HPX TechCo Inc., a private mineral exploration company.

Sama Resources Inc. is listed on the TSX Venture and trades under the ticker symbol SME.

Ed Milewski:  Oh, it’s a mining thing. This is our new…Okay, good, good.

Marc-Antoine Audet: This is

Lithoquest Diamonds Inc (CVE:LDI) is a diamond exploration company primarily focused on its North Kimberley Diamond Project in Western Australia. CEO Bruce Counts discusses the site’s potential for diamond discovery. During the company’s first drill program in 2018 kimberlite was found, which indicates the site has diamond-bearing sources. Lithoquest has identified 15 to 20 key targets for its upcoming drill program and Counts wants a 30 percent success rate for hits. Counts notes that the company raised $5 million during its RTO and he expects this year’s drill program to cost approximately $2 million. Counts addresses current commodities pricing and the potential for diamond projects to be exceptionally profitable. He notes that Rio Tinto Ltd’s (OTCMKTS:RTNTF) (FRA:CRA1) Argyle mine, which produces 40 percent of the world’s diamonds, will be coming off the market in a few years, and this should raise the value of lower quality diamonds.

James West:   My guest today is Bruce Counts. He’s the CEO of Lithoquest Diamonds Inc., trading on the TSX Venture under the symbol LDI. Bruce, welcome.

Bruce Counts: Thank you very much.

James West:   Bruce, as the name suggests, you’re in the diamond ex

48North Cannabis Corp (CVE:NRTH) (OTCMKTS:NCNNF) Co-CEOs Alison Gordon and Jeannette VanderMarel are thrilled the company’s stock has surged by 40 percent this week. The pair believe 48North’s company Q2 financials, which announced 48North was EBITDA-positive, has made an impression on the market. Gordon and VanderMarel discuss 48North’s recent deal with the SQDC, the only legal retailer of recreational cannabis in Quebec, for 1,200 kilos of outdoor grown cannabis. 48North recently launched a brand of accessories, F8, and announced F8 products will be available through the OCS and Toyko Smoke shops, a subsidiary of Canopy Growth Corp (TSE:WEED) (NYSE:CGC) (FRA:11L1).

Howard Glassman:   All right, we’re here with the co-CEOs of 48North Cannabis Corp. Our guests today, the very talented and lovely pair of Jeannette VanderMarel, that’s you.

Jeannette VanderMarel:  That’s me.

Howard Glassman:   Look at you! You seem very nice.

Amex Exploration Inc (CVE:AMX) (OTCMKTS:AMXEF) (FRA:MX0) VP Exploration Kelly Malcolm is ecstatic about the company’s 2019 drill program. Malcolm notes that the high-grade gold project has a very affordable $160/m cost to drill thanks to existing infrastructure at the Quebec site. Amex recently announced it would drill an additional 10,000 metres at the site and that it is hitting visible gold in almost all its drill holes. The company has made all its drilling data publicly available and Malcolm is confident investors will like what they see. Amex recently announced a $5.4 million private financing and the addition of Eric Sprott as a strategic investor.

Ed Milewski:  I’m joined now by Kelly Malcolm, VP Exploration, Amex Exploration. How are you doing?

Kelly Malcolm: Thanks for having me on. I’m doing very well, thank you. PDAC is busy, we’ve got a really exciting story, and we’ve had a lot of meetings that –

Ed Milewski:  Unbelievable story.

Kelly Malcolm: Very exciting high-grade gold in Quebec, great infrastructure. We’ve got a lot of traction in the market, and the management team is very excited about this story.

Cannabis Growth Opportunity Corp (CNSX:CGOC) (OTCMKTS:CWWBF) offers investors an actively managed, diversified portfolio of companies operating in the cannabis space. COO Jamie Blundell explains that the company takes a long-term approach and provides retail investors with the opportunity to invest in private companies in addition to publicly-traded entities. CGOC also invest internationally, including in the US cannabis space. He reveals that when investing in private companies, CGOC looks for mid-to-late stage pre-IPO companies poised to break onto the scene. CGOC typically holds between 18 to 20 public and 10 to 15 private cannabis companies in its portfolio. CGOC’s holdings include US consolidator C21 Investments Inc (CNSX:CXXI), whose recent run has grabbed the attention of many investors.

Narrator: Cannabis Growth Opportunity Corporation is a cannabis-focused investment corporation with both public and private cannabis holdings. The company’s main objective is to provide shareholders long-term total return through its management portfolio of securities related to products or services in the cannabis industry.

Cannabis Growth Opportunity Corporation is listed on the CSE and trades under the ticker symbol CGOC.

Howard Glassman:   All right. As we’ve been sort of leading to, our guest today: Jamie Blundell is the COO of Cannabis Growth Opportunity Corporation. Jamie, welcome to the show.

Jamie Blundell:    Great, thank you very much. Happy to be here.

<

Cannex Capital Holdings Inc (CNSX:CNNX) (OTCMKTS:CNXXF) CEO Anthony Dutton explains that the company’s stock has been halted, per CSE regulations, as a result of the transformational definitive agreement with 4Front Holdings, LLC. The move combines Cannex’s cultivation and processing expertise with 4Front’s retail and regulatory experience. It also makes Cannex an MSO, with holdings in 6 states, as 4Front has operations on the East Coast as well as Illinois and Arizona. Dutton also discusses Cannex’s products and reveals that the company has 7 of the top 10 edibles brands and the top 2 flower brands in Washington State. Cannex is well-capitalized and received a $32 million investment from influential cannabis investors Gotham Green Partners, LLC in November.

Narrator:   Cannex Capital Holdings, Inc. is a Vancouver-based company providing real estate management, financial branding, and IP support to its licensed cannabis business operators domestically and internationally.

Cannex is focused on premium indoor cultivation, extraction, manufacturing and branding of edible and derivative products, as well as retail operations.

Cannex Capital Holdings, Inc. is listed on the CSE and trades under the ticker symbol CNNX.

Howard Glassman: My name is Howard Glassman from the Humble & Fred show. Thanks for joining us. How are you today, sir?

Anthony Dutton:    Hi, Howard. I’m very well, nice to meet you.

Howard Glassman:   Well, it’s nice to meet you. I mean, there’s lots of stuff going on with your company, a lot of things that we’ve want

CB1 Capital Management CIO Todd Harrison talks about what makes 1933 Industries Inc (CNSX:TGIF) (OTCMKTS:TGIFF) an important investment for CB1 Capital. Harrison discusses what he thinks the big stories will be in the cannabis space in 2019, including the possibility of banking reform in the United States. Harrison comments on the current acquisition growth strategy employed by many MSOs. He notes that while it is hard to extrapolate what brands will be successful, CB1 Capital is interested in management teams and companies with existing distribution footprints. Harrison discusses three phases of market moves (denial, migration, panic), suggesting that the cannabis space is still in denial, and believes that cannabis represents a longer tail secular bull market.

James West:   Everybody on our chat group has been asking us to ask you about TGIF, 1933 Industries.

Todd Harrison: Okay, sure. So you know, 1933 is a company that, you know, we own a big slug of stock, we’ve owned the stock for some time, largely because we think it’s real attractive. Their brands are great; CannaHemp, and certainly we think the stock is attractive, that’s why we own a lot of it. And then working with the company, we identified some synergies that would allow us to advise them and help them, through some strategic relationships, and certainly, you know, we couldn’t be happier. We’re big fans of the company, we’re big fans of the team, and so far, so good. It’s a good alliance for us, and we think it’s going to work out well for everybody.

James West:   Sure. So the team that launched 1933 Industries recently launched a company called Weekend Unlimited, which won the symbol POT. Are you invested n that company as well?

Todd Harrison: No, not right now. You know, 1933 is our vehicle, and certainly we’re working with them on a range of different initiatives right now. So it doesn’t preclude anything in the future, but you know, right now, that’s what it is.

James West:   Sure. 1933 Industries is focused primarily on US markets, correct?

Todd Harrison: Yeah. Their hemp brands are certainly focused on US markets; they have a pretty good operation in Nevada, which was actually what initially attracted us to them. You know, the Nevada market is pretty robust, and their brands are doing pretty well out there. So you know, one of the things that we look for at CB1, and we’ve been doing this for some time, now, is, because Wall Street doesn’t have a presence, you know, in the space yet, there’s a lot of inefficiencies, certainly, that exist that wouldn’t otherwise exist if Wall Street had a more ubiquitous presence, as we believe they will in the years to come, if not the months to come.

So certainly, we think that as Wall Street adopts, institutions do the work and run the numbers, a lot

VitalHub Corp (CVE:VHI) (FRA:6OV) President & CEO Dan Matlow is excited about the company’s recent acquisition of The Oak Group Inc. The Oak Group is a UK-based software and service provided with expertise in patient flow data. Matlow believes the acquisition of Oak Group’s data and software will help VitalHub resolve the issues that lead to “hallway medicine,” and provides a product that is scalable and can create organic growth. Oak Group’s technology provides VitalHub with both an operational and a diagnostic sales route, which creates greater opportunity for partnerships with government agencies and for international deals. Matlow reveals the company recently created an M&A committee to further drive acquisitions and consolidation efforts.

James West:   Dan Matlow joins me now, CEO of VitalHub Corp., trading on the TSX Venture under the symbol VHI. Dan, welcome back.

Dan Matlow:   Thanks for having me again.

James West:   Dan, every time we turn around, your stock inches up a little higher, so things are obviously going good.

Dan Matlow:   So far, knock on wood, we’re executing on our plans. So we continue to move forward, and the public is starting to get aware of what we’re doing, so we’re excited.

James West:   Yeah, beautiful. And so, tel

Medexus Pharmaceuticals Inc (CVE:MDP) (OTCMKTS:PDDPF) (FRA:P731) CEO Ken d’Entremont provides an overview of the company and highlights its latest financial reporting. The company is the results of the recent amalgamation of three specialty pharmaceutical companies: Pediapharm Inc, Medexus Inc, and Medac Pharma. As d’Entremont explains, the combined entity provides Medexus Pharmaceuticals with a footprint in both Canada and the United States, while expanding its therapeutic expertise to include pediatrics, autoimmune diseases, oncology, and rheumatology. The merger was undertaken to allow the company to rapidly scale. Further, Medexus Pharmaceuticals can now drive revenue while opex stays flat, benefiting from the organic growth of a larger product portfolio. Medexus Pharmaceuticals announced Q3 Fiscal 2019 revenues of $14.4 million, a 512 percent increase year-over-year.

Narrator: Medexus Pharmaceuticals Inc. is a Montreal-based specialty pharmaceutical company focused on the therapeutic areas of autoimmune disease and pediatrics.

The company’s leading products are Rasuvo and Metoject, unique formulations designed to treat rheumatoid arthritis and other autoimmune diseases.

Another leading product is Rupall, an innovative allergy medication with a unique mode of action.

Medexus Pharmaceuticals Inc. trades on the TSX Venture under the ticker symbol MDP.

National Access Cannabis Corp (CVE:META) (OTCMKTS:NACNF) (FRA:1HV) is a cannabis-based health care service provider, offering education and care through its network of clinics and retail locations. The company pivoted into the recreational market to bring health, wellness, and safety to consumers. CEO Mark Goliger is pleased the company has the largest footprint of retail stores in Canada, with 24 locations across the country. Subject to license availability, National Access Cannabis intends to double that footprint in 2019. Under its retail brand NewLeaf Cannabis, National Access Cannabis has captured 20 percent of the licensed retail outlets in Alberta. Through its Meta Cannabis Supply Co retail brand, the company’s share of the Manitoba retail market is even greater, at 33 percent. Goliger believes retail sales will be a significant part of the legal cannabis industry and suggests National Access Cannabis is currently undervalued given its retail and medical success.

Narrator: National Access Canada is a healthcare service provider that specializes in prescribing medical cannabis and provides members with ongoing education and care.

Through its network of medical cannabis clinics, partner pharmacies, clinical research division made a cannabis supplying company in New Leaf cannabis retail stores, the company enables patients access to Canada’s network of authorized licensed producers of cannabis.

National Access Cannabis is listed on the TSX Venture Exchange under the symbol META.